Orencia clickject 125 MG/mlml
Ended Awarded
- Contract number
- SPE2DR26F3N4A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,592
Award facts
- Contract value 100% obligated
- $34,591.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,591.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-set-aside delivery order is being performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. Orencia (abatacept) is a biologic immunosuppressant used to treat rheumatoid arthritis and other autoimmune conditions, reflecting DLA's procurement of specialty pharmaceutical products to support military and federal healthcare systems.
This delivery order represents a task order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle running through December 2026 that serves as a global pharmaceutical support mechanism for military healthcare programs. As one of the largest pharmaceutical distributors in the United States, AmerisourceBergen maintains a significant federal contracting portfolio with DLA, supplying an extensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The vendor's consistent receipt of competitive, non-set-aside awards demonstrates its capability to meet rigorous federal procurement standards while supporting critical medical supply chains for the Department of Defense and other federal healthcare entities.
Quick answers
Who was awarded contract SPE2DR26F3N4A?
SPE2DR26F3N4A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F3N4A worth?
The government has obligated $34,592 on SPE2DR26F3N4A.
Is contract SPE2DR26F3N4A an order under another contract?
Yes. SPE2DR26F3N4A is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3N4A competed?
The extent of competition for SPE2DR26F3N4A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award